Trial Search Results

Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes

The primary objective of this study is to determine whether intermittent use of continuous glucose monitor will facilitate weight loss in individuals who are overweight/obese with prediabetes.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Stanford Investigator(s):


  • Device: CGM
  • Other: Dietitian




Inclusion Criteria:

   - Overweight/obese (BMI 25-40 kg/m2)

   - Prediabetes (fasting glucose 100-125 mg/dL and/or HbA1c 5.7-6.4%)

Exclusion Criteria:

   - On glucose-lowering medications (e.g., metformin)

   - On weight-loss medications

Ages Eligible for Study

18 Years - 99 Years

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Associate Professor
Not Recruiting